APTOF
Aptose Biosciences Inc.
Key Financials
Net Income
$-25468000
↓ 0.1%
Total Liabilities
$37.2M
↑ 153.4%
EPS (Diluted)
$-10.41
↑ 71.4%
Total Assets
$10.0M
↓ 1.1%
Shareholders' Equity
$-27167000.00
↓ 498.0%
Cash & Equivalents
$935000.00
↓ 84.8%
Operating Cash Flow
$-21990000.00
↑ 38.9%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| SC 13E3/A | 4/1/2026 | View on SEC |
| 10-K | 3/31/2026 | View on SEC |
| 8-K | 3/31/2026 | View on SEC |
| 8-K | 3/31/2026 | View on SEC |
| RW | 3/23/2026 | View on SEC |
| 8-K | 3/23/2026 | View on SEC |
| 8-K | 3/23/2026 | View on SEC |
| 8-K | 3/19/2026 | View on SEC |
| 8-K | 2/24/2026 | View on SEC |
| SC 13E3/A | 2/24/2026 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | APTOF |
| Company Name | Aptose Biosciences Inc. |
| CIK | 882361 |
| Sector | Biological Products, (No Diagnostic Substances) |
| Industry | Non-accelerated filer Smaller reporting company |
| Exchange | OTC |
| SIC Code | 2836 |
| SIC Description | Biological Products, (No Diagnostic Substances) |
| Entity Type | operating |
| Fiscal Year End | 1231 |
| State of Incorporation | A6 |
| Phone | 310-849-8060 |